U.S. Asthma/COPD Market

Published by: Frost & Sullivan

Published: Oct. 23, 2007 - 149 Pages

Table of Contents

1. Executive Summary

1. Executive Summary

1. Introduction

2. Market Introduction

1. Overview

1. Scope and Segmentation

2. Research Methodology

2. Disease Overview

1. Asthma

2. COPD

3. Treatment Options

3. Market Overview

1. Market Engineering Measurements

2. Industry Challenges and Strategic Recommendations

3. Market Drivers

4. Market Restraints

3. Total Market Analysis

1. Competitive Analysis

1. Competitive Structure

2. Patient Forecasts

1. Patient Forecasts - Asthma

2. Patient Forecasts - COPD

3. Total Patient Forecasts

3. Revenue Forecasts

1. Total Market Revenue Forecasts

2. Market Share Analysis

4. Bronchodilators Market

1. Introduction

1. Introduction

2. Market Engineering Measurements

3. Revenue Forecasts

4. Market Share Analysis

2. Short-Acting Beta-2 Agonists Market

1. Introduction

2. Revenue Forecasts

3. Product Analysis

4. Pipeline Analysis

3. Long-Acting Beta-2 Agonists Market

1. Introduction

2. Revenue Forecasts

3. Product Analysis

4. Pipeline Analysis

4. Anticholinergics Market

1. Introduction

2. Revenue Forecasts

3. Product Analysis

4. Pipeline Analysis

5. Combination Bronchodilators

1. Introduction

2. Revenue Forecasts

3. Product Analysis

4. Pipeline Analysis

5. Anti-Inflammatory Market

1. Introduction

1. Introduction

2. Market Engineering Measurements

3. Revenue Forecasts

4. Market Share Analysis

2. Inhaled Corticosteroids Market

1. Introduction

2. Revenue Forecasts

3. Product Analysis

4. Pipeline Analysis

3. Mediator-Release Inhibitor Market

1. Introduction

2. Revenue Forecasts

3. Product Analysis

4. Pipeline Analysis

4. Anti-Leukotriene Market

1. Introduction

2. Revenue Forecasts

3. Product Analysis

4. Pipeline Analysis

5. Monoclonal Antibody Market

1. Introduction

2. Revenue Forecasts

3. Product Analysis

4. Pipeline Analysis

6. Other Emerging Anti-Inflammatories

1. Pipeline Analysis

6. Combination Therapies Market

1. Combination Therapies

1. Introduction

2. Market Engineering Measurements

3. Revenue Forecasts

4. Product Analysis

5. Pipeline Analysis

7. Appendix

1. Decision Support Databases

1. Mortality Due to Asthma Bronchitis and Emphysema

2. Prevalence of Asthma

3. Prevalence of Chronic Obstructive Pulmonary Disease

4. Female Population 65 and Above

5. Male Population 65 and Above

List of Figures

Chapter 2

Asthma/COPD Market: Major Market Challenges (U.S.), 2007-2013

Asthma/COPD Market: Market Drivers Ranked in Order of Impact (U.S.), 2007-2013

Asthma/COPD Market: Market Restraints Ranked in Order of Impact (U.S.), 2007-2013

Chapter 3

Asthma/COPD Market: Competitive Structure (U.S.), 2006

Asthma/COPD Market: Diagnosed Male Asthma Patient Population Forecasts by Age Group (U.S.), 2003-2013

Asthma/COPD Market: Diagnosed Female Asthma Patient Population Forecasts by Age Group (U.S.), 2003-2013

Asthma/COPD Market: Diagnosed Asthma Patient Population Forecasts by Gender (U.S.), 2003-2013

Asthma/COPD Market: Diagnosed COPD Patient Population Forecasts by Gender (U.S.), 2003-2013

Asthma/COPD Market: Diagnosed Asthma and COPD Patient Population Forecasts by Disease (U.S.), 2003-2013

Asthma/COPD Market: Diagnosed Asthma and COPD Patient Population Forecasts by Gender (U.S.), 2003-2013

Asthma/COPD Market: Revenue Forecasts (U.S.), 2003-2013

Asthma/COPD Market: Revenue Forecasts by Market Segment (U.S.), 2003-2013

Asthma/COPD Market: Revenue Forecasts by Disease (U.S.), 2003-2013

Asthma/COPD Market: Company Market Share by Revenues (U.S.), 2006

Chapter 4

Bronchodilators Market: Revenue Forecasts (U.S.), 2003-2013

Bronchodilators Market: Company Market Share by Revenues (U.S.), 2006

Short-Acting Beta-2 Agonists Market: Revenue Forecasts (U.S.), 2003-2013

Short-Acting Beta-2 Agonists Market: Product Analysis - Albuterol (U.S.), 2006

Short-Acting Beta-2 Agonists Market: Product Analysis - Others (U.S.), 2006

Short-Acting Beta-2 Agonists Market: Product Analysis - Xopenex HFA (U.S.), 2006

Short-Acting Beta-2 Agonists Market: Pipeline Analysis (U.S.), 2006

Long-Acting Beta-2 Agonists Market: Revenue Forecasts (U.S.), 2003-2013

Long-Acting Beta-2 Agonists Market: Product Analysis (U.S.), 2006

Long-Acting Beta-2 Agonists Market: Product Analysis - Foradil Aerolizer (U.S.), 2006

Long-Acting Beta-2 Agonists Market: Selected Pipeline Analysis (U.S.), 2006

Anticholinergics Market: Revenue Forecasts (U.S.), 2003-2013

Anticholinergics Market: Product Analysis (U.S.), 2006

Anticholinergics Market: Product Analysis - Spiriva Handihaler (U.S.), 2006

Anticholinergics Market: Selected Pipeline Analysis (U.S.), 2006

Combination Bronchodilators Market: Revenue Forecasts (U.S.), 2003-2013

Combination Bronchodilators Market: Product Analysis (U.S.), 2006

Combination Bronchodilators Market: Product Analysis - Combivent Inhalation Aerosol (U.S.), 2006

Combination Bronchodilators Market: Selected Pipeline Analysis (U.S.), 2006

Chapter 5

Anti-Inflammatory Market: Revenue Forecasts (U.S.), 2003-2013

Anti-Inflammatory Market: Company Market Share by Revenues (U.S.), 2006

Inhaled Corticosteroids Market: Revenue Forecasts (U.S.), 2003-2013

Inhaled Corticosteroids Market: Product Analysis (U.S.), 2006

Inhaled Corticosteroids Market: Product Analysis - Pulmicort Respules (U.S.), 2006

Inhaled Corticosteroids Market: Selected Pipeline Analysis (U.S.), 2006

Mediator-Release Inhibitors Market: Revenue Forecasts (U.S.), 2006-2013

Mediator-Release Inhibitors Market: Product Analysis (U.S.), 2006

Mediator-Release Inhibitors Market: Product Analysis - Intal Inhaler (U.S.), 2006

Mediator-Release Inhibitors Market: Pipeline Analysis (U.S.), 2006

Anti-Leukotrienes Market: Revenue Forecasts (U.S.), 2003-2013

Anti-Leukotrienes Market: Product Analysis (U.S.), 2006

Anti-Leukotrienes Market: Product Analysis - Singulair (U.S.), 2006

Anti-Leukotrienes Market: Selected Pipeline Analysis (U.S.), 2006

Monoclonal Antibody Market: Revenue Forecasts (U.S.), 2003-2013

Monoclonal Antibody Market: Product Analysis (U.S.), 2006

Monoclonal Antibody Market: Product Analysis -Xolair (U.S.), 2006

Monoclonal Antibody Market: Selected Pipeline Analysis (U.S.), 2006

Other Emerging Anti-Inflammatories Market: Selected Pipeline Analysis (U.S.), 2006

Chapter 6

Combination Therapies Market: Revenue Forecasts (U.S.), 2003-2013

Combination Therapies Market: Product Analysis (U.S.), 2006

Combination Therapies Market: Product Analysis - Advair (U.S.), 2006

Combination Therapies Market: Selected Pipeline Analysis (U.S.), 2006

Abstract

This Frost & Sullivan research service titled U.S. Asthma/COPD Market provides an overview of the medication used to treat asthma and COPD and provides forecasts for the patient population and market revenues, along with a complete analysis of key market drivers, restraints, and challenges that are impacting this market. In this research, Frost & Sullivan's expert analysts thoroughly examine bronchodilators, anti-inflammatories, and combination therapies.

This analysis is available through our Pharmaceuticals & Biotechnology Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

• Pharmaceuticals
• Respiratory
• Biotechnology
• COPD
• Asthma

Technologies

The following technologies are covered in this research:

• Bronchodilators
• Anti-inflammatories
• Combination therapies

Market Overview

Growth Expected in the U.S. Asthma/Chronic Obstructive Pulmonary Disease Market

The number of patients diagnosed with either asthma or chronic obstructive pulmonary disease (COPD) is expected to continue to increase in the United States. In addition, increased awareness about these diseases and more screenings will contribute to the expansion of the patient population. "The total patient population for asthma and COPD is growing," notes the analyst of this research service. "The escalation in the patient population and the development of innovative new products that address unmet needs is expected to drive growth in this market and create opportunity for revenue expansion."

Increased Awareness Vital for Improved Rates of Diagnosis

One of the major obstacles facing the U.S. asthma and COPD market is the low level of awareness about the early symptoms of both asthma and COPD. Patients with mild forms of these diseases often go undiagnosed and untreated. "Knowledge about early symptoms and the importance of proper disease management are relatively inadequate," notes the analyst of this research service. "Furthermore, this lack of awareness can lead to low diagnosis rates, poor disease control, and increase in emergency care."

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.